American College of Obstetricians and Gynecologists
ACOG Practice Bulletin. Clinical Management Guidelines for Obstetrician-Gynecologists: number 41, December 2002
Abstract
Polycystic ovary syndrome (PCOS) is a condition of unexplained hyperandrogenic chronic anovulation that most likely represents a heterogenous disorder. Its etiology remains unknown, and treatment is largely symptom based and empirical. Recent findings suggest PCOS has substantial metabolic sequelae, including risk of diabetes and possibly cardiovascular disease, and that primary treatment should focus on metabolic sequelae. The purpose of this document is to examine the best available evidence on the diagnosis and clinical management of PCOS.
Source and rights
Published by Obstetrics and gynecology, 2002. The guideline itself is at the source linked here.
Prognia summarises this guideline for reference and education. It is not medical advice. Always check the official guideline and current local protocols before acting on it.
At a glance
- Organisation
- American College of Obstetricians and Gynecologists
- Published
- 2002
- Applies to
- 🇺🇸 United States
- Scope
- National
- Journal
- Obstetrics and gynecology
- PubMed
- 12468195
- Added to Prognia
- 25 July 2026
More in obstetrics and gynaecology
- Expert opinion by the Italian Society of Gynecology of the Third Age (SIGiTE) and the Italian Society of Menopause (SIM) on diagnosis and treatment of premature ovarian insufficiencyEuropean Respiratory Society · 2026
- Preexisting diabetes: Expert consensus from the College of French Gynecologists and Obstetricians and from the French Society of DiabetologyCollege of French Gynecologists and Obstetricians and French Society of Diabetology · 2026
